A carbapenem-resistant Pseudomonas aeruginosa strain (PA41437) susceptible to expanded-spectrum cephalosporins was recovered from several consecutive lower-respiratory-tract specimens of a patient who developed a ventilator-associated pneumonia while hospitalized in an intensive care unit. Cloning experiments identified OXA-198, a new class D ␤-lactamase which was weakly related (less than 45% amino acid identity) to other class D ␤-lactamases. Expression in Escherichia coli TOP10 and in P. aeruginosa PAO1 led to transformants that were resistant to ticarcillin and showed reduced susceptibility to carbapenems and cefepime. The bla OXA-198 gene was harbored by a class 1 integron carried by a ca. 46-kb nontypeable plasmid. This study describes a novel class D ␤-lactamase involved in carbapenem resistance in P. aeruginosa.
Carbapenem drugs are often used for treating infections due to multidrug-resistant isolates (2) . However, resistance to these antibiotics increases, leading to an ever-restricted therapeutic choice. In Pseudomonas aeruginosa, resistance to ␤-lactam agents can be due to the overproduction of chromosomeencoded cephalosporinase (23) , to the alteration of the outer membrane protein OprD (36, 37) , to the overexpression of the efflux system (36, 37) , and to the acquisition of exogenous ␤-lactamases (28) . Among these, class B carbapenemases (i.e., VIM and IMP) and to a lesser extent some class A extendedspectrum ␤-lactamases (ESBLs) (i.e., GES, KPC) have been involved in the resistance of P. aeruginosa to carbapenems and are considered the transferable resistance determinants having the highest clinical impact on antimicrobial therapy in hospitals worldwide (41) .
Carbapenem-hydrolyzing class D ␤-lactamases (OXA-23, OXA-40, OXA-58, OXA-143) (CHDLs) are almost exclusively found in multidrug-and carbapenem-resistant Acinetobacter baumannii (6, 14, 16, 18, 34) . In P. aeruginosa, to the best of our knowledge, only OXA-40 has been detected in two clonally unrelated clinical isolates resistant to imipenem in Spain (38, 39) . In these two isolates, the bla OXA-40 gene was located on a 32-kb plasmid also found in the A. baumannii SM28 strain isolated in the same hospital (25, 38, 39) .
In this study, we have identified a new CHDL, , that belongs to a new group of class D ␤-lactamases in a clinical isolate of P. aeruginosa.
MATERIALS AND METHODS
Bacterial strains and antimicrobial susceptibility. A P. aeruginosa clinical isolate (PA41437) was recovered from the culture of a sputum specimen of an elderly patient hospitalized at the UCL Mont-Godinne University Hospital (Yvoir, Belgium) in April 2010. Bacterial species identification was confirmed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) with a Microflex LT mass spectrometer (Bruker Daltonik GmbH, Leipzig, Germany). P. aeruginosa reference strain PAO1 (40) , P. aeruginosa PU21 (19) , and Escherichia coli TOP10 (Invitrogen, Merelbeke, Belgium) were used for plasmid transfer and/or cloning experiments. Susceptibility to antimicrobials was determined by Etest (bioMérieux, Brussels, Belgium) on Mueller-Hinton (MH) agar plates (Bio-Rad, Nazareth, Belgium) and interpreted according to CLSI breakpoints (10) .
PCR sequencing of bla and of porin-coding genes. Detection of OXA ␤-lactamase genes (bla OXA-1 group, bla OXA-2 group, bla OXA-10 group, bla OXA-9 , bla , bla OXA-18 ), penicillinase genes (bla PSE/CARB ), and genes encoding class A ESBL enzymes (GES, VEB, PER, BEL) and metallo-␤-lactamases (VIM, IMP) was achieved by PCR as previously described (4, 5) . The genetic context of the bla gene was assessed by PCR sequencing of the variable region of the integron by using primers designed on the basis of the 5Ј and 3Ј conserved segments (CS) of class 1 integron (22) and by primer walking sequencing performed directly on the purified p41437 plasmid using an external sequencing service (Macrogen, Seoul, South Korea).
Nucleotide sequences were analyzed with the BLASTN algorithm available from the National Center for Biotechnology Information (http://www.ncbi.nlm .nih.gov/BLAST/). PCR sequencing of the gene encoding the outer membrane protein OprD was achieved with primers oprD-FW (5Ј-CTTCCTTTATAGGC GCGTTG-3Ј), oprD-RV (5Ј-AACATAAGACATGCCGTGGA-3Ј), and oprD1 to oprD4 (15) .
Plasmid analysis, mating out, and electroporation experiments. Plasmid DNA was extracted by the Kieser method (20) or by the QIAfilter plasmid midikit (Qiagen, Venlo, The Netherlands). E. coli NCTC50192, harboring four plasmids of 154, 66, 38, and 7 kb, was used as a plasmid size marker. Plasmid DNA was analyzed by electrophoresis with a 0.7% agarose gel. Determination of the incompatibility groups of plasmids was done as described by Carattoli et al. (7), as the authors were able to type some P. aeruginosa plasmids belonging to IncP and IncA/C. The transfer of the resistance marker from P. aeruginosa (PA41437) to P. aeruginosa PU21 (rifampin resistant) was attempted by solid and liquid mating out assays at 37°C (24) . Selection was performed on brain heart infusion (BHI) agar plates supplemented with ticarcillin at 100 g/ml and rifampin at 100 g/ml. Moreover, plasmid DNA extracts from P. aeruginosa PA41437 were electroporated into P. aeruginosa PAO1 and in E. coli TOP10 using a Gene Pulser II (Bio-Rad, Marnes-la-Coquette, France) as previously described (3, 8) , and transformants were selected on BHI agar plates containing 100 g/ml of ticarcillin.
Cloning of OXA-198 ␤-lactamase. PCR-generated DNA fragments was confirmed by sequencing on both strands. The obtained plasmid, pOXA-198, was then electroporated in the wild-type reference P. aeruginosa PAO1 as previously described (3, 8) , and transformants were selected on BHI agar plates containing 100 g/ml of ticarcillin and 20 g/ml of gentamicin (selecting marker of pUCP24).
Isoelectric focusing analysis. Analytical isoelectric focusing (IEF) was performed on freeze-thaw crude culture extracts with an ampholine polyacrylamide gel on pH 3 to 9 PhastGel medium with Phastsystem (Amersham Biosciences, Uppsala, Sweden) according to the manufacturer's protocol, with the only exception being that the migration step was performed at 500 V instead of 2,000 V.
␤-Lactamase extraction and purification. OXA-198 ␤-lactamase was extracted and purified as previously described (18, 33, 34) with slight modifications. Briefly, E. coli TOP10 harboring recombinant plasmid pOXA-198 was grown until A 600 reached 1 at 37°C in 4 liters of BHI broth (BD, Erembodegem, Belgium) containing 100 g/ml of amoxicillin and 15 g/ml of gentamicin. The bacterial suspension was pelleted, resuspended in 100 mM phosphate buffer (pH 7.0), and lysed using a cell disrupter Emulsiflex-C3 (Avestin, Mannheim, Germany). The crude extract was then treated with benzonase endonuclease (Merck, Darmstadt, Germany) as recommended by the supplier and centrifuged at 16,000 ϫ g for 30 min at 4°C. The supernatant was dialyzed against 20 mM Tris-H 2 SO 4 buffer (pH 8.0), filtered through a 0.45-m filter, and loaded on a Q-Sepharose ion exchange chromatography column equilibrated with the same buffer. The ␤-lactamase was recovered in the flowthrough. The extract was then dialyzed in 20 mM CHES (N-cyclohexyl-2-aminoethanesulfonic acid) buffer (pH 10.0) and loaded again onto the Q-Sepharose column equilibrated with the same buffer. Elution was performed with a K 2 SO 4 gradient. The fractions containing the highest ␤-lactamase activities were pooled and dialyzed against 100 mM phosphate buffer (pH 7.0). Enzyme purity was estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The protein content was measured by the Bio-Rad DC protein assay (Bio-Rad, Nazareth, Belgium).
Kinetic studies. Purified ␤-lactamase kinetic parameters (k cat and K m ) were determined by UV spectrophotometry at 30°C in 100 mM sodium phosphate (pH 7.0) as previously described (13, 31) . The 50% inhibitory concentration (IC 50 ) was determined as the inhibitor (clavulanate or NaCl) concentration that reduced the hydrolysis rate of 100 M nitrocefin by 50% under conditions in which the enzyme was preincubated with various concentrations of inhibitor for 3 min at 30°C before the addition of the substrate (31, 33) . Specific activity of the ␤-lactamase OXA-198 was defined as the amount (unit of enzyme) that hydrolyzed 1 mol of benzylpenicillin/minute/milligram of protein.
Microbiological assay of carbapenemase activity. Carbapenem hydrolysis activity of OXA-198 was phenotypically investigated on crude extract of PA41437 with a modified method of Masuda et al., as previously described (6, 26) . Briefly, an MH agar plate was inoculated with the ATCC 25922 E. coli strain, and a disk of imipenem (10 g) or meropenem (10 g) was placed at the center of the plate.
Four filter paper disks containing 20, 10, and 5 l of crude extract or 20 l of sodium phosphate buffer (pH 7.0) were placed 15 mm and 25 mm from the imipenem and meropenem disks, respectively. Plates were incubated overnight at 37°C, and inactivation of imipenem or meropenem was shown by growth of the ATCC 25922 strain within the expected inhibition zone.
Nucleotide sequence accession number. The nucleotide sequence data reported in this paper have been assigned to the EMBL/GenBank nucleotide sequence database under accession number HQ634775.
RESULTS

Origin of the clinical isolate and antibiotic susceptibility.
The P. aeruginosa PA41437 strain was isolated from consecutive lower-respiratory-tract specimens of a 79-year-old man with no travel history and who had been admitted at the UCL Mont-Godinne University Hospital in April 2010 for acute exacerbation of chronic bronchitis. Initial sputum specimens yielded the presence of a multidrug-resistant Enterobacter aerogenes strain in pure culture, and the patient was treated for 8 days with meropenem (1 g three times a day [TID]). Subsequently, the patient had to be transferred to the intensive care unit (ICU), where he had to be intubated and mechanically ventilated because of severe hypoxemia and major acute respiratory failure. During his stay in the ICU, he developed an aspiration pneumonia, and repeated quantitative cultures of endotracheal aspirates yielded the presence of P. aeruginosa (PA41437) in significant amounts (Ͼ10 6 CFU/ml). The in vitro susceptibility pattern of the P. aeruginosa PA41437 isolate is shown in Table 1 . PA41437 was resistant to most ␤-lactams, including imipenem, but it presented an intermediate susceptibility to meropenem. However, it remained susceptible to ceftazidime and to aztreonam. This strain was also resistant to aminoglycosides (gentamicin, amikacin, and tobramycin) and to ciprofloxacin. Following obtention of the microbiological results, the patient was treated with ceftazidime (2 g TID) for one additional week, but he eventually died due to acute renal failure and cardiac insufficiency. 
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Plasmid content, conjugation experiment, and ␤-lactamase analysis. Extraction of plasmid content of clinical strain PA41437 by the Kieser method revealed the presence of a single nontypeable plasmid, p41437, of ca. 46 kb (data not shown). Transfer of p41437 in wild-type P. aeruginosa PAO1 or in wild-type E. coli TOP10 by electroporation led to transformants resistant to ticarcillin, tobramycin, and amikacin and with reduced susceptibility to piperacillin, piperacillin-tazobactam, carbapenems, cefepime, and gentamicin (Table 1) . A conjugation experiment with clinical strain PA41437 or PAO1 p41437 as the donor and rifampin-resistant P. aeruginosa PU21 as the recipient failed to yield transconjugants. ␤-Lactamase content analysis of culture extracts of the PA41437 clinical strain or of PAO1 transformants harboring p41437 by isoelectric focusing (IEF) showed a ␤-lactamase band with a pI of 6.4. All PCR screening assays were negative for metallo-␤-lactamases, ESBLs, and class D ␤-lactamases (4, 5) (data not shown), leading to the hypothesis that the p41437 plasmid harbored an unknown ␤-lactamase.
Cloning and sequencing of OXA-198. PCR was done on p41437 plasmid DNA with consensus primers targeting 5Ј CS and 3Ј CS of class 1 integrons (22) . A 3,000 bp PCR fragment was amplified and yielded three open reading frames (ORFs): (i) an aacA7 gene which encodes the AAC(6Ј)-Ib enzyme; (ii) an undescribed 789-bp bla OXA gene (GC content of 47.8%), named bla , which encodes a ␤-lactamase with 83% amino acid identity with a ␤-lactamase of Chlorobaculum parvum NCIB 8327; and (iii) a cmlA1 gene which encodes a chloramphenicol efflux protein. Analysis of the genetic environment of bla was performed by primer walking on p41437. Figure 1 shows that bla was part of a class 1 integron very similar to that described in the transposon Tn6060 of a clinical strain of P. aeruginosa (9) . Upstream of the aacA7 gene, the intl1 gene, coding for an integrase, was found. Upstream of the 5Ј CS end of the integron, we found IRi inverted repeats flanked by paeR7IM and paeR7IN genes (accession number DQ839391) coding for an adenine-specific methyltransferase and a DNA invertase, respectively. Downstream of the bla gene cassette and the cmlA1 gene, we found the 3Ј CS fragment containing qacE⌬1, sul1, and orf5 genes. The tniB and tniA genes involved in transposition were located downstream of orf5 (Fig. 1) .
bla (21, 35, 42) (Fig. 2) . OXA-198 was weakly related to other carbapenem-hydrolyzing class D ␤-lactamases sharing 35%, 32%, and 30% amino acid identity with OXA-48, -58, and -143, respectively, and 29% with OXA-51, -23, and -40 (Fig. 3) . Cloning of bla in the shuttle vector pUCP24 and expression in E. coli TOP10 or P. aeruginosa PAO1 led to transformants with reduced susceptibility to ticarcillin, piperacillin, piperacillin-tazobactam, carbapenems, and cefepime (Table  1) . However, the MIC values of carbapenems for the transformants remained lower than that observed for the clinical isolate PA41437, suggesting that other mechanisms could account for the resistance to carbapenems. Sequencing of the gene coding for the porin OprD in the clinical strain compared to that of PAO1 revealed several mutations and a deletion of 88 nucleotides, which led to a truncated protein lacking the first 110 amino acids (data not shown).
Biochemical properties of ␤-lactamase OXA-198. After purification from extracts of E. coli TOP10 harboring recombinant plasmid pOXA-198, the specific activity of OXA-198 against benzylpenicillin was 2.2 U/mg of protein, and its purification factor was 210-fold. The protein purity was estimated to be Ͼ95% by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis (data not shown). OXA-198 has a narrow-spectrum hydrolysis profile, including mostly penicillins (Table 2) . No activity could be detected against cefotaxime, ceftazidime, cefepime, and aztreonam, as observed for other CHDLs. The rates of imipenem and meropenem hydrolysis were low, with k cat values of 0.1 s Ϫ1 and 0.01 s Ϫ1 for imipenem and meropenem, respectively (Table 2) , although the MICs of both carbapenems for OXA-198-expressing PAO1 were 2-to 3-fold increased ( Table 1) . As previously described for other CHDLs, hydrolysis of imipenem was faster than that of meropenem (35) . Determination of K m values for imipenem and meropenem (0.15 and 0.006 M, respectively) showed that OXA-198 has a strong affinity for carbapenems even if hydrolysis is low, resulting in a high k cat /K m ratio (670 and 1,670 mM Ϫ1 s Ϫ1 , respectively). In comparison to values obtained for benzylpenicillin, the k cat /K m ratios for meropenem and imipenem were 1.5-fold higher and 2-fold lower, respectively (Table 2). A positive modified Masuda test (6, 26) performed on a crude sonicated extract of E. coli TOP10 expressing OXA- 
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EL GARCH ET AL. ANTIMICROB. AGENTS CHEMOTHER. imipenem or meropenem hydrolysis by OXA-198 (Fig. 4) . In general, the catalytic activities of OXA-198 were in the same range as those of others CHDLs, such as OXA-58 or OXA-40 (34) . Studies of activity inhibition, as measured by IC 50 determination, showed that OXA-198 was inhibited by NaCl (IC 50 , 37 mM) like many other class D ␤-lactamases (30, 35) . Interestingly, OXA-198 activity was also inhibited by clavulanic acid (IC 50 , 7 M), with concentrations in the same range as that reported for OXA-163, another CHDL with a weak activity against carbapenems (32) .
DISCUSSION
In this study, we have characterized a new carbapenemhydrolyzing class D ␤-lactamase, OXA-198, in P. aeruginosa. This class D ␤-lactamase was only weakly related to other CHDLs, and it constitutes a novel subclass of CHDLs. OXA-198 ␤-lactamase hydrolyzed penicillins and to a lesser extent carbapenems but had no significant hydrolytic activity against expanded-spectrum cephalosporins, as also observed with other CHDLs (6, 17, 18, 34) . It is, however, likely that OXA-198 may contribute to decreased susceptibility to carbapenem, as confirmed by the modified phenotypic Masuda test (6, 26) . Comparison of the resistance phenotype of P. aeruginosa clinical strain PA41437 and of its transformants highlighted that additional mechanisms were responsible for the high level of carbapenem resistance. This was substantiated by the observation of various mutations and of a deletion of 88 nucleotides in the oprD gene which led to a truncated protein lacking the first 110 amino acids (data not shown). Our study constitutes the second description of a carbapenem-hydrolyzing class D ␤-lactamase in P. aeruginosa, after that of Sevillano et al., who reported the presence of OXA-40 on a plasmid also carried by A. baumannii (38) . fide-rich hot springs (1), suggesting the possible environmental acquisition of this new class D ␤-lactamase by P. aeruginosa. Acquisition of this ␤-lactamase by P. aeruginosa on a class 1 integron carried by a plasmid which can easily be transformed in P. aeruginosa or E. coli could lead to the dissemination of this class D ␤-lactamase. Moreover, this integron is very similar to that carried by the Tn6060 transposon found on a genomic island in a VIM-1-positive clinical strain of P. aeruginosa and easily transposable to a conjugative plasmid (9) .
